Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:08 PM
Ignite Modification Date:
2025-12-24 @ 2:08 PM
NCT ID:
NCT04517695
Eligibility Criteria:
Inclusion Criteria:
* Confirmed SARS-CoV-2 or bacterial infection
* Patient admitted to the ICU
* Patient age is between 18 and 95 years
* Patent peripheral or central venous line from which blood draws can be made and through which the 131I bolus can be administered
* Arterial catheter considered indicated by primary team caring for the patient
Exclusion Criteria:
* Refused informed consent to participate in the study
* Pregnant or possible pregnant women
* Patient unlikely to survive more than 72h
* Patient with life sustaining treatment limitations (use of renal replacement therapy)
* Patient already on or likely to be placed on extra-corporeal membrane oxygenation support within 48h after admission
* Known allergy to iodine or iodinated 131I albumin
* Patients with chronic renal failure requiring renal replacement therapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
95 Years
Study:
NCT04517695
Study Brief:
Protocol Section:
NCT04517695